GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Weekly CEO Buys Highlight: Citigroup Inc, ARIAD Pharmaceuticals Inc, Bruker BioSciences Corp, Akamai Technologies Inc, The Greenbrier Companies Inc.

August 08, 2009 | About:


Last week's top five stocks that were bought by their CEOs were ARIAD Pharmaceuticals Inc, Bruker BioSciences Corp, Akamai Technologies Inc, and The Greenbrier Companies Inc. According to GuruFocus Insider Data, these are the largest CEO buys during the past week.

Citigroup Inc. (C): CEO, Citibank, N.A. Eugene M Mcquade Bought 1,000,000 Shares

CEO, Citibank, N.A. of Citigroup Inc. (C) Eugene M Mcquade bought 1,000,000 shares on 08/05/2009 at an average price of $3.85. Citigroup Inc. the leading global financial services company has some two hundred million customer accounts and does business in more than hundred countries providing consumers corporations governments and institutions with a broad range of financial products and services including consumer banking and credit corporate and investment banking securities brokerage and wealth management. Major brand names under Citigroup's trademark red umbrella include Citibank CitiFinancial Primerica Smith Barney and Banamex. Citigroup Inc. has a market cap of $21.15 billion; its shares were traded at around $3.85 with and P/S ratio of 0.3. Citigroup Inc. had an annual average earning growth of 5.1% over the past 10 years.

Citigroup recently reported its second quarter results for the year. The company said that its second quarter net income was $4.3 billion, or 49 cents per share (diluted). The company also said that it earned $1.4 billion by its Smith Barney gains.

Bill Nygren owns 4,500,000 shares as of 06/30/2008, an increase of 45.16% from the previous quarter. Kenneth Fisher owns 54,662 shares as of 06/30/2009, an increase of 22.84% from the previous quarter. Charles Brandes owns 8,841,809 shares as of 03/31/2009, a decrease of 76.19% of from the previous quarter. This position accounts for 0.14% of the $16.16 billion portfolio of Brandes Investment. Six gurus sold out their positions in the company.

Citigroup's CEO's purchase of 1 million shares shows his confidence in the company.Eugene M Mcquade joined CitiGroup as its CEO on July 9. Before that, he served as the Vice Chairman of Merill Lynch, and was COO of Freddie Mac, and President of Bank of America.

ARIAD Pharmaceuticals Inc. (ARIA): Chairman & CEO Harvey J M D Berger Bought 1,714,286 Shares

Chairman & CEO of ARIAD Pharmaceuticals Inc. (ARIA) Harvey J M D Berger bought 1,714,286 shares on 08/04/2009 at an average price of $1.9. Ariad Pharmaceuticals is engaged in the discovery and development of novel pharmaceuticals based on intracellular signaling technology. The Company has a market cap of $165 million; its shares were traded at around $1.9 with and P/S ratio of 23.4. ARIAD Pharmaceuticals Inc. had an annual average earning growth of 12.1% over the past 5 years.

ARIAD recently reported its second quarter results. The company said that it had a net loss of 24 cents per share, compared to a net loss of 25 cents per share a year ago. For the two quarters of 2009, the company reported a loss of 50 cents per share, compared to 49 cents per share a year ago.

Buy: Senior VP, Chief Medical Off Pierre F Dodion bought 5,714 shares of ARIA stock on 08/04/2009 at the average price of $1.75; the price of the stock has increased by 8.57% since.

Bruker BioSciences Corp. (BRKR): CEO/President, 10% Owner Frank H Laukien Bought 150,000 Shares

CEO/President, 10% Owner of Bruker BioSciences Corp. (BRKR) Frank H Laukien bought 150,000 shares during the past week at an average price of $10.18. As of February 26 2008 the renamed BRUKER CORPORATION has become the parent company of the entire Bruker group of companies. After the closing of the acquisition of the Bruker BioSpin Group Bruker Corporation now operates in two segments the life science and analytical (LSA) systems segment and the international advanced superconductor (IAS) segment. Bruker BioSciences Corp. has a market cap of $1.67 billion; its shares were traded at around $10.18 with a P/E ratio of 24.2 and P/S ratio of 1.5.

Bruker recently reported its second quarter results. The company reported a revenue of $252.5 million, and a GAAP Net income of $12.9 million. It also announced that its GAAP EPS was 8 cents per diluted share, and free cash flow was $32.8 million.

Sell: 10% Owner  Marc M Laukien sold 2,100,000 shares of BRKR stock on 05/07/2009 at the average price of $6.91; the price of the stock has increased by 47.32% since.

Akamai Technologies Inc. (AKAM): President & CEO Paul Sagan Bought 30,000 Shares

President & CEO of Akamai Technologies Inc. (AKAM) Paul Sagan bought 30,000 shares on 07/31/2009 at an average price of $19.46. Akamai Technologies Inc. is the leading global service provider for accelerating content and business processes online. Thousands of organizations have formed trusted relationships with Akamai improving their revenue and reducing costs by maximizing the performance of their online businesses. Leveraging the Akamai EdgePlatform these organizations gain business advantage today and have the foundation for the emerging Web solutions of tomorrow. Akamai Technologies Inc. has a market cap of $3.36 billion; its shares were traded at around $19.46 with a P/E ratio of 14.4 and P/S ratio of 4.3.

AKAM recently reported its second quarter results. The company said that its revenue was $204.6 million, up 5% compared to results from a year ago. GAAP net income was $36 million, also up 5% year-over-year. The company reported record cash from from operations of $105 million.

PRIMECAP Management owns 1,354,200 shares as of 03/31/2009, an increase of 54.03% from the previous quarter. This position accounts for 0.06% of the $41.21 billion portfolio of PRIMECAP Management.Ruane Cunniff owns 100,000 shares as of 03/31/2009, which accounts for 0.03% of the $6.33 billion portfolio of Ruane & Cunniff & Goldfarb Inc. Two gurus recently sold out their holdings in the company.

Many other insiders other than the company's CEO have also been increasing their positions in the company. Buy: Executive Chairman  George H Conrades bought 126,430 shares of AKAM stock on 08/03/2009 at the average price of $16.61; the price of the stock has increased by 17.16% since.

The Greenbrier Companies Inc. (GBX): President & CEO William A Furman Bought 30,000 Shares

President & CEO of The Greenbrier Companies Inc. (GBX) William A Furman bought 30,000 shares during the past week at an average price of $11.8. Greenbrier Companies Inc. is a leading supplier of transportation equipment and services to the railroad and related industries. The manufacturing segment produces double-stack intermodal railcars conventional railcars and marine vessels and performs repair and refurbishment activities for both intermodal and conventional railcars. In addition to manufacturing they are engaged in complementary leasing and services activities. The Greenbrier Companies Inc. has a market cap of $197.3 million; its shares were traded at around $11.8 with and P/S ratio of 0.1. The Greenbrier Companies Inc. had an annual average earning growth of 3.4% over the past 10 years.

Greenbrier recently reported its third quarter 2009 results. The company announced that it had a net loss of $3 per share. Revenue was down 36%.

John Keeley owns 1,964,700 shares as of 03/31/2009, which accounts for 0.15% of the $4.75 billion portfolio of Keeley Fund Management.

Apart from the company's CEO, many other insiders have been reducing their positions in the company.

For the complete list of stocks that bought by their company CEOs, go to: CEO Buys.

About the author:

guruyt
Mark's equity focus is identifying secular growth trends, and the companies most likely to benefit from these macro trends. Stocks are identified through fundamental analysis, although basic technical analysis is used in determining entry and exit points. With a degree in Economics from the University of Michigan, a broader understanding of the economy as a whole, along with interpreting investor psychology is also a major interest for Mark. His career background has focused on financial analysis in corporate America. Visit Mark's website at http://www.fundmymutualfund.com/

Visit guruyt's Website


Rating: 3.9/5 (10 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK